Matthew Duffy serves as Managing Partner of Laidlaw Venture Partners. Prior to joining Laidlaw, Mr. Duffy served as President and Chief Operating Officer at AltMed Enterprises, LLC. In this role, he was instrumental in raising over $35 million and facilitating a $7 million private stock sale. Prior to this, Mr. Duffy gained over 15 years of experience as an investment banker, buy-side and sell-side equity research analyst, and investor relations professional. He served as Managing Director at Roberts Mitani, LLC, a global healthcare-focused investment bank and as Managing Director at LifeSci Partners, LLC.
Mr. Duffy has developed broad industry experience through his commercial and senior leadership roles at Pfizer, MedImmune, Lev Pharmaceuticals, and CorMedix. He worked previously with Managing Partner Patrick Gallagher in co-founding Black Diamond Research, LLC, a sell-side equity research firm specializing in healthcare and biotechnology. Matt currently serves on the boards and/or management teams of Algorithm Sciences, Inc, Lucius Partners, LLC, Voltron Therapeutics, Inc, PD Theranostics, Inc., AerWave Medical, Inc. and NRx Pharmaceuticals, Inc.
He holds the following FINRA licenses: 7, 63 and 65. Matthew Duffy is a proud alumnus of Duke University.